We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EQH:NYSEEquitable Holdings, Inc. Analysis

Data as of 2026-03-13 - not real-time

$37.14

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Equitable Holdings is trading at $37.14, well below its 20‑day ($40.92), 50‑day ($44.23) and 200‑day ($49.12) simple moving averages, indicating a sustained bearish price trend. The RSI of 28 signals oversold conditions, while the MACD histogram remains negative, reinforcing short‑term downside pressure. The stock hovers just above its technical support level of $36.79 and faces resistance near $45.81, with a 30‑day volatility of over 43% and a beta exceeding 1.3, suggesting heightened price swings. Despite these challenges, the DCF fair value of $47.49 implies a potential upside of more than 60%, and analysts collectively rate the stock as a strong buy with median price targets around $59. Recent material news highlights a new $1 billion share‑repurchase program and a consistent dividend yield of 2.91%, which together provide tangible shareholder return catalysts. However, the company’s negative profit margin, a book value per share of –$4.03, and a debt‑to‑equity ratio above 400% raise concerns about the sustainability of those payouts. The juxtaposition of a deep valuation discount against a fragile balance sheet defines the current investment narrative for EQH.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Oversold RSI indicating potential rebound
  • Proximity to technical support at $36.79
  • Upcoming share‑repurchase execution

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF implied upside of >60% to $47.5
  • Analyst consensus strong‑buy with median target $59
  • Attractive dividend yield supporting total return

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Structural exposure to retirement and life‑insurance demand
  • High leverage and negative book value limiting upside
  • Sustained dividend and share‑repurchase program providing cash returns

Key Metrics & Analysis

Financial Health

Revenue Growth-14.20%
Profit Margin-11.82%
P/E Ratio4.1
ROE-38.87%
ROA-0.20%
Debt/Equity429.64
P/B Ratio-9.2
Op. Cash Flow$714.0M
Free Cash Flow$-9656625152
Industry P/E16.4

Technical Analysis

TrendBearish
RSI28.2
Support$36.79
Resistance$45.81
MA 20$40.92
MA 50$44.23
MA 200$49.12
MACDBearish
VolumeStable
Fear & Greed Index72.27

Valuation

Fair Value$47.49
Target Price$60.42
Upside/Downside62.67%
GradeUndervalued
TypeValue
Dividend Yield2.91%

Risk Assessment

Beta1.41
Volatility43.34%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.